Dyne Therapeutics, Inc. (DYN) Free cash flow 2019–2025
Dyne Therapeutics, Inc. (DYN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$405.1MFY2025 · since FY2019: -$13.5M → -$405.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$405.1M | -37.4% |
| FY2024 | -$294.7M | -56.0% |
| FY2023 | -$188.9M | -20.5% |
| FY2022 | -$156.7M | -27.2% |
| FY2021 | -$123.2M | -158.4% |
| FY2020 | -$47.7M | -253.6% |
| FY2019 | -$13.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice